Neoadjuvant Durvalumab Plus Gemcitabine And Cisplatin (D+Gemcis) Versus Gemcis Alone For Localized Biliary Tract Cancer (Btc): Results Of A Randomized, Multicenter, Open-Label, Phase II Trial (Debate)
Cisplatin;Durvalumab;Gemcitabine;Gemcis
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Neoadjuvant Durvalumab Plus Gemcitabine And Cisplatin (D+Gemcis) Versus Gemcis Alone For Localized Biliary Tract Cancer (Btc): Results Of A Randomized, Multicenter, Open-Label, Phase II Trial (Debate) ### Output: Cisplatin;Durvalumab;Gemcitabine;Gemcis